TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209. A total of 19 filers reported holding TRACON PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $14,966 | -77.7% | 34,822 | -13.3% | 0.00% | – |
| Q3 2022 | $67,000 | -19.3% | 40,179 | -2.7% | 0.00% | – |
| Q2 2022 | $83,000 | -61.8% | 41,279 | -50.0% | 0.00% | -100.0% |
| Q1 2022 | $217,000 | -60.9% | 82,500 | -58.8% | 0.00% | 0.0% |
| Q4 2021 | $555,000 | -55.2% | 200,404 | -37.3% | 0.00% | -66.7% |
| Q3 2021 | $1,238,000 | -23.7% | 319,775 | +27.9% | 0.00% | -25.0% |
| Q2 2021 | $1,623,000 | -36.3% | 250,059 | -19.2% | 0.00% | -42.9% |
| Q1 2021 | $2,547,000 | -10.9% | 309,487 | +26.7% | 0.01% | -12.5% |
| Q4 2020 | $2,859,000 | +1543.1% | 244,362 | +175.4% | 0.01% | +700.0% |
| Q2 2020 | $174,000 | +185.2% | 88,728 | +148.6% | 0.00% | – |
| Q1 2020 | $61,000 | – | 35,686 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 4,190,000 | $6,997,000 | 2.89% |
| Ikarian Capital, LLC | 2,765,530 | $4,618,000 | 0.92% |
| Telemetry Investments, L.L.C. | 97,000 | $162,000 | 0.21% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $48,000 | 0.07% |
| JOHNSON & JOHNSON | 84,003 | $140,000 | 0.04% |
| NEA Management Company, LLC | 346,719 | $579,000 | 0.03% |
| X-Square Capital, LLC | 17,973 | $30,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 258,844 | $432,000 | 0.01% |
| LINDEN ADVISORS LP | 454,916 | $760,000 | 0.01% |
| DOWLING & YAHNKE LLC | 47,455 | $79,000 | 0.00% |